LiverRight and Aegle Medical Solutions Partner to Expand Liver Disease Detection and Care

LiverRight and Aegle Medical Solutions, LLC have announced a strategic partnership aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients throughout the United States. The collaboration brings together Aegle Medical's advanced liver assessment technology and implementation services with LiverRight's national virtual liver clinic, creating a more connected pathway for healthcare organizations to move patients efficiently from liver disease identification to specialist review and longitudinal management.

For physicians, health systems, and independent practices, the partnership offers a way to establish or expand comprehensive liver disease programs without building every component internally. Aegle Medical provides a consultative approach to technology evaluation, implementation, training, and ongoing support, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems. LiverRight complements this with same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. The company's Liververse™ referral system coordinates bloodwork, patient-reported outcomes, available imaging, diagnosis, and longitudinal disease management.

The partnership addresses a critical need: a significant number of adults in the United States live with undiagnosed liver disease. By bringing advanced liver assessment into the outpatient setting and providing timely specialist interpretation, the collaboration aims to help providers identify liver disease earlier and improve access to specialist expertise, particularly in communities where hepatology specialists may be limited.

Central to the technology offering is the Mindray Hepatus platform, which introduces Visualized Transient Elastography (ViTE), a next-generation advancement beyond conventional transient elastography. ViTE integrates real-time B-mode ultrasound visualization directly into the elastography examination, allowing operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while obtaining quantitative liver stiffness and attenuation measurements. This evolution combines the efficiency of transient elastography with the clinical confidence of real-time ultrasound visualization in a single examination. The Hepatus platform provides liver stiffness measurement (LSM) for fibrosis assessment and Liver UltraSound Attenuation (LiSA) for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands capabilities by combining these with diagnostic ultrasound imaging, enabling abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound depending on configuration.

LiverRight's clinicians are licensed across all 50 U.S. states and support adult patients with conditions including MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The partnership allows health systems, GI and hepatology practices, and independent providers to offer a scalable approach to expanding liver services under their own brand. For more information on Aegle Medical Solutions, visit https://www.aeglemedicalsolutions.com. For more information on LiverRight, visit https://www.liverright.com.